A B S T R A C T The T cell proliferative response to autologous non-T cells is termed the autologous mixed lymphocyte reaction (AMLR). Recent studies have suggested that the AMLR represents an inducer circuit for the activation of T8+ suppressor/cytotoxic effector cells. Since atopic dermatitis (AD) patients are deficient in T8+ cytolytic T cell function, we investigated the AMLR in AD. When sheep erythrocytes were used to separate T cells from non-T cells, the AMLR was found to be significantly decreased (P < 0.001) in AD patients (n = 11; Acpm = 1,550±393) when compared with normal control subjects (n = 13; Acpm = 25,819±4,609). To exclude the possibility that these results were an artifact of the sheep erythrocyte separation, T cells were also separated on a fluorescenceactivated cell sorter after treatment of peripheral blood lymphocytes with the OKT3 monoclonal antibody. AD T cells separated by the latter method were also found to have a significantly reduced AMLR response when compared with similarly treated normal T cells. Co-culture studies using cells from AD patients and their HLA identical siblings indicated that the defect resided at the responder T cell level rather than at the stimulator non-T cell level. Co-culture studies revealed no evidence for excessive suppressor cell activity resulting in the decreased AMLR. However, enumeration of T cells reactive with the monoclonal antibody T29, which recognizes a subset of T cells proliferating in the AMLR, demonstrated that AD patients (n = 8; % T29 = 2.5±0.7) had a significantly decreased (P < 0.001) number of circulating T29+ T cells when compared with normal controls (n = 8; % T29
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INTRODUCTION
Defective cell-mediated immunity has been reported in up to 80% of patients with atopic dermatitis (AD)'
(1-5). Clinically, these patients are susceptible to develop disseminated viral infections with herpes simplex and vaccinia viruses (5) . This in vivo observation correlates with in vitro experiments showing that the majority of AD patients are unable to generate normal T8+ cytotoxic T cell activity after allogeneic stimulation (6) . Furthermore, the latter study also demonstrated that the defect in generation of cytotoxic T cells resided in both the helper/inducer T4+ cells and the effector T8+ cells. Since recent studies suggest that the autologous mixed lymphocyte reaction (AMLR) represents an inducer circuit for the activation of T8+ effector cells (7), the current investigation was carried out to determine whether AD patients had a defective AMLR and, if so, to determine the cellular basis of this defect.
METHODS
Subjects. The study population consisted of 16 patients with chronic AD, nine males and seven females, 4-40 yr of age. They all satisfied the criteria suggested by Hanifin and Lobitz (5) for the diagnosis of AD, and had moderate to severe chronic AD defined by multiple sites of skin involvement for at least 3 mo, as well as a personal and/or family ' Isolation of peripheral blood mononuclear cell (PBMC).
PBMC were isolated from heparinized venous blood by means of Ficoll-Hypaque gradient density centrifugation and incubated on plastic petri dishes for 30 min at 370C to remove excess macrophages, which have been shown to suppress the AMLR (7). The nonadherent cells were rosetted with sheep erythrocytes (E) and fractionated into T cells (E+) and non-T cells (E-) as previously described (8) .
AMLR and allogeneic mixed lymphocyte reaction (MLR Fig. 1 . The mean AMLR of 13 normal age-matched controls was 25,819±4,609 cpm above background. The AMLR of 11 AD patients averaged only 1,550±392 cpm and was significantly depressed (P < 0.01) compared with normal subjects and controls (P < 0.001). In contrast, the AMLR in five subjects with miscellaneous skin diseases was not significantly different from the normals (P > 0.1). There was no significant difference between background cpm in AD subjects and control subjects. Although the results obtained for each patient are represented only once in Fig. 1 , several patients and normal controls were tested on multiple occasions (up to five times) over a 1-yr period and the results were unchanged. Furthermore, in two AD patients studied on multiple occasions, the AMLR remained abnormally low regardless of whether they were in short term remission (<6 mo) or had active skin disease.
The AMLR response of three AD patients and four normal controls were also determined after separation of T3+ T cells from T3-non-T cells in a FACS-IV cell sorter. As shown in Table I nificantly lower than that of normal controls (Acpm = 24,685±5,534; P < 0.02). These results suggest that the basis for the decreased AMLR in AD was not due to an abnormal proliferative response to E antigens. In contrast to the impairment of the AMLR, allogeneic MLR in patients with AD was normal. Allogeneic MLR determined in eight out of the 11 patients with AD (mean±SEM of Acpm = 54,524±10,047) was not significantly different (P > 0.3) from the allogeneic MLR determined in eight control subjects (mean±SEM of Acpm = 60,107±7,902).
Cellular basis of the impaired AMLR in AD. To determine whether the impaired AMLR was due to a defect of responder T cells, stimulator cells, or both, two AD patients and their healthy HLA-identical siblings were studied. In these experiments, T cells from a patient, from an HLA-A-, B-, and DR-identical sibling and from an unrelated normal subject were cultured with non-T cells from each of these three donors. The results in Table II show that T cells from the healthy HLA-identical siblings were stimulated equally well by autologous non-T cells and by the patient's non-T cells (Table II, lines 2 and 5, columns 3 and 4) . In contrast, T cells from the patients did not proliferate in response to either autologous non-T cells or HLAidentical normal non-T cells (Table II, lines 1 and 4,  columns 3 and 4) . These results suggested that the defect in AD patients resided at the level of the responder T-cell, rather than at the level of the stimulator non-T cells. The deficiency in T cell response was not generalized because the patients' T cells response to allogeneic non-T cells was equivalent to that of T cells from their HLA-identical siblings (Table II , column 5).
The possibility that suppressor T cells were responsible for the decreased AMLR in AD was tested by studying the effect of the addition of T cells from two AD patients to the AMLR of their healthy HLA-identical siblings. As shown in Fig. 2 , T cells from AD patients did not possess excessive suppressor cell activity for the AMLR. These was no significant difference (P > 0.1) in proliferation when normal T cells were stimulated with autologous non-T cells in the presence of absence of HLA-identical AD T cells.
Enumeration of T29 cells in AD. The possibility that the decreased AMLR in AD was accompanied by a numerical reduction of autoreactive T cells was considered. To test this possibility, T cells from normal controls and AD patients were enumerated for reactivity with the T29 monoclonal antibody, previously shown to react with a subpopulation of T cells that proliferate in the AMLR. As shown in Fig. 3 , the T29 antigen was present on 10.4±0.8% of normal T cells (12) and systemic lupus erythematosus (13) may be due to defective responder T cells, whereas a defect of autologous stimulator cells has been described in patients with mononucleosis (14) and chronic lymphocytic leukemia (15) .
The T cell defect in AMLR was neither generalized nor appeared to be the result of excess suppressor cells. Indeed, T cells from patients with AD proliferated normally to allogeneic cells. Suppression of the AMLR by non-T cells was not a factor, since non-T cells from the patients were excellent stimulators of HLA-identical normal T cells (Table II) . Suppression by T cells was tested for and ruled out in co-culture experiments in which T cells from AD patients were added to the AMLR of their normal HLA-identical siblings (Fig. 2) .
The defective AMLR in AD could have resulted from a functional and/or numerical impairment of T cells committed to the AMLR. Two subpopulations of T cells are known to paticipate in the AMLR. One population bears the surface antigen recognized by the T29 monoclonal antibody and proliferates in response to adherent monocytes. A second population lacks the T29 surface antigen and responds to nonadherent Ecells, i.e., B cells and null cells (7) . Our studies show a deficiency in the T29+ population in AD (Fig. 2) . The major portion of the proliferative AMLR response is due to T29-cells (7, 9) . Because the mean AMLR of AD patients was <10% of the normal AMLR, it is
DISCUSSION
Our data indicate that the T cells of patients with AD respond poorly to autologous non-T cells. Similar results were obtained whether T cells were separated on the basis of rosetting with E or cell sorting after treatment with the OKT3 monoclonal antibody. The defective AMLR in AD was not simply secondary to the skin inflammation, because other patients with skin disease had normal AMLR (Fig. 1 ) and because, in two patients with AD who were studied on multiple occasions, impaired AMLR was present even during short term remissions (<6 mo), i.e., when they had no evidence of skin disease.
Reciprocal mixing experiments using cells from the patients and from their healthy HLA-identical siblings indicated that a defect in responder T cells rather than in stimulator non-T cells was the basis of the defective AMLR in AD. Indeed, in each of two cases studied, T cells from the healthy HLA-identical sibling mounted normal proliferative responses to both autologous and AD non-T cells. Patients' T cells, however, failed to respond to either autologous or normal sibling's non-T cells. Similar experimental approaches by other in30k (4) i -. likely that the T29-population as well as the T29+ cells were deficient (functionally and/or numerically).
The deficient AMLR in patients with AD has to be viewed in the context of other immunoregulatory abnormalities present in this disease and in the light of the cellular events that occur in the AMLR. The subset of AMLR reactive T cells includes T cells that proliferate in response to soluble antigens (9) . In this regard, lymphocytes from AD patients proliferate poorly in response to candida and tuberculin antigens (16) . Isolated T4+ cells proliferate in the AMLR whereas isolated T8+ cells do not (17, 18) . However, in the presence of T4+ cells, T8+ cells will proliferate; this suggests that the AMLR can function as an inducer circuit for the activation of T8+ effector cells (17) . A variety of effector functions have been attributed to AMLRactivated T cells. They include the induction of cytotoxic T cells (19, 20) , of helper T cells (21, 22) , and of suppressor T cells (12, 23) . In this regard the majority of patients with AD are deficient in T8+ cytolytic T cell function (6) . This deficiency has been shown to be due in part to the failure of their T4+ helper cells to induce normal T8+ cytotoxic T cell function (6) . Further studies are required to delineate the relationship between the deficient AMLR and impaired induction of cytolytic T cells in patients with AD.
